Cisplatin cancer treatment
WebSep 10, 2010 · Cisplatin is the first agent of platinum drugs, which was approved in 1978 for the treatment of testicular and ovarian cancer . In view of its considerable toxicity profile, many attempts have been made to develop analogues … WebFeb 16, 2024 · Cisplatin is used together with other cancer drugs to treat bladder cancer, testicular cancer, or ovarian cancer. Cisplatin may also be used for purposes not listed …
Cisplatin cancer treatment
Did you know?
WebThe TPF triplet regimen (docetaxel, cisplatin, and 5‐FU) has a trend of further improving treatment efficacy compared with the traditional doublet regimen. 35 , 36 In a phase II … Web2 days ago · Testicular cancer, also known as testicular germ cell tumors (TGCT), is the most common type of cancer in young men. When treated with cisplatin, the tumor cells …
WebApr 12, 2024 · That phase 3 study included 410 patients with locally advanced or metastatic CCA, gallbladder cancer, or ampullary cancer. Patients who received treatment with … WebApr 12, 2024 · That phase 3 study included 410 patients with locally advanced or metastatic CCA, gallbladder cancer, or ampullary cancer. Patients who received treatment with cisplatin and gemcitabine had a median OS of 11.7 months, whereas patients in the gemcitabine cohort had a median OS of 8.1 months (p < .001).
WebFeb 1, 2024 · James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a ... WebTreatment of lung cancer, the most common type of carcinoma, is difficult due to disease progression at the time of diagnosis, causing a high mortality rate. 1, 32 Cisplatin (DDP), also known as cis-diaminodichloplatin, is a powerful nonspecific drug blocking the cell cycle. 33, 34 DDP can enter cells through the passive transport.
WebCisplatin is a heavy metal compound that inhibits synthesis of RNA, DNA, and protein in cells. All of these compounds are vital for cells to divide and grow. By preventing them …
WebFeb 16, 2024 · Use: For advanced testicular cancer Usual Adult Dose for Ovarian Cancer 75 to 100 mg/m2 by slow IV infusion once every 3 to 4 weeks on Day 1 Comments: The dosing presented is manufacturer suggested. Other doses and combination regimens have been used. Use: For advanced ovarian cancer Usual Adult Dose for Bladder Cancer sharesource connectivity platformWebJan 18, 2024 · CX is the name of a combination of chemotherapy drugs; cisplatin and capecitabine. It is a treatment for a number of different types of cancer. Find out about … sharesource bem vindoWebJun 1, 2024 · Hearing loss is a side effect of one of the most common cancer treatments: cisplatin. Though effective at fighting most solid tumor cancers, the drug ... Some cancers require treatment with cisplatin in conjunction with say, radiation. If that radiation is close to the ear—for example, on the head and neck—that radiation can increase ... sharesource dkWebSep 3, 1991 · After a preliminary dose-finding study involving 12 patients with advanced or locally recurrent head and neck cancer, 27 patients were treated on a phase II protocol, using fluorouracil 350 mg/m2/d by continuous intravenous (IV) infusion over 5 days, followed on the sixth day by a 2-hour IV infusion of cisplatin 50 mg/m2, administered during the … popit food containersWebA standard therapy for women with advanced epithelial ovarian cancer in the United States is an alkylating agent plus cisplatin. Cisplatin-based combination therapy has been found to be more... sharesource customer service numberWebApr 3, 2024 · The researchers explained that cisplatin and other platinum-based chemotherapeutic agents are the most common types of agents used in chemotherapy for solid malignancies, with at least 500,000... sharesource companyWebMar 16, 2024 · A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861 ... share source fidelity do vs sp